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Abstract
Background: Cervical ectopic pregnancy (CEP) is a rare and dangerous form of ectopic
pregnancy in which the blastocyst is installed within the endo-cervical canal. CEP
diagnosis requires special awareness to evaluate patient precisely. Individualizing
controversial medical and surgical management strategies is of importance in medical
practice.
Case: A 35-year-old nulliparous woman on her 9th week of pregnancy was referred to
our hospital with vaginal bleeding preliminary misdiagnosed as aborting intrauterine
pregnancy. Transvaginal ultrasound revealed an empty uterus and a viable triplet
pregnancy just below the level of internal os. Cervical curettage after cerclage suture
placement procedure removed conception tissues completely. Consequently, in the
next few hours vaginal bleeding decreased tominimal amount and vital signs remained
within normal limits and there was no hematocrit change. On follow-up day 32, serum
B-HCG became negative.
Conclusion: CEP diagnosis requires special attention and awareness to evaluate
patient precisely along with skillful assessment of possible risk factors. Lifesaving
treatment beside fertility preservation was successful with pre-curettage cerclage.
Key words: Cervical pregnancy, Cervical triplet pregnancy, Cervical cerclage,
Methotrexate.
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1. Introduction
Ectopic pregnancy (EP) is the implantation of
blastocyst outside of the uterus cavity which
accounts for approximately 6% of total pregnan-
cies. Despite the modest incidence of EP, it remains
the leading cause of hemorrhage, mortality, and
morbidity during the first gestational trimester (1-3).
Cervical ectopic pregnancy (CEP) is a rare form
of EP in which the blastocyst is installed within
the endo-cervical canal. This type of pregnancy
constitutes approximately 0.005% to 0.04% of
pregnancies (4) and accounts for 3.7% of in-vitro-
fertilization (IVF) ectopic pregnancies (5). The rich
cervical vascularity, the incongruence of cervical
biomechanics with gestational advancements, and
the negligible incidence of CEP can significantly
increase the potential of hemorrhage leading to
mortality, morbidity, and infertility of the affected
individual (6).
So, early diagnosis and appropriate conservative
treatment especially in a woman’s reproductive age
is of great importance both for the patient and
the physician. To the best of our knowledge, there
is no previous report of viable triplet CEP in the
literature. The objective of this case report is to
introduce a rare case of triplet cervical pregnancy
that infiltrated most of the cervix, and the diag-
nostic challenge the patient encountered and our
management strategy for her fertility preservation.
2. Case Presentation
A 35-yearr-old pregnant woman G3A2 pre-
sented to Shariati Hospital, Tehran, Iran, with vagi-
nal bleeding on March 30th, 2018. Her pregnancy
was achieved by Intra Cytoplasmic Sperm Injec-
tion and Embryo Transfer performed on February
10th, 2018 in another IVF clinic in the country.
From March 4th, she experienced an episode
of heavy vaginal bleeding and then intermittent
spotting and bleeding episodes without cramp-
ing pain. At the beginning, the ultrasound report
was not significant, and the local health center
diagnosed the problem as threatened abortion.
Due to gradually aggravated bleeding, she was
presented to our emergency department. The
patient reported culmination an hour in advance
of her admission. She did not report constitutional
symptoms, nausea, vomiting, abdominal pain, flank
pain, irritative and obstructive urinary symptoms,
and odorous vaginal discharge supporting septic
abortion. She had a three-year male factor primary
infertility, unsuccessful IVF in 2015, and a two-year
secondary infertility after two complete abortions
without any dilation and curettage (D&C) proce-
dure. She had a history ofmildMitral Valve prolapse
and a small sub-serousal fibromyoma. The patient
consumed routine gestational supplementary and
denied tobacco and alcohol consumption. She did
not experience pelvic inflammatory disease and
previous pelvic surgery.
On physical examination, the patient was fully
oriented and afebrile. Vital signs were stable. The
abdomen was soft and non-tender. The patient’s
vaginal examination revealed a moderate hem-
orrhage with soft but closed cervical external
os and normal-appearing vulva, vestibule, vaginal
canal. She hadminimal cervical motion tenderness.
Other findings were unremarkable. The patient
also revealed a sonogram report of March 29th,
intrauterine pregnancy with signs of incomplete
abortion from endo-cervix area. The patient also
carried a normal cell count and 𝛽-HCG > 50,000
mIU/mL.
Upon arrival, her hemoglobin and hematocrit
were 10.0 g/dL and 30%, respectively; serum
𝛽-HCG was 58399 mIU/mL. The transvaginal
ultrasound scans surprisingly revealed a 10-mm
endometrium but empty uterus and a live triplet
pregnancy just below the level of internal os.
Cervix was enlarged and the total diameter of
the trophoblast was about 7 cm; the cervix was
Page 522 https://doi.org/10.18502/ijrm.v17i7.4864
International Journal of Reproductive BioMedicine Pre-curettage cerclage in a triplet cervical pregnancy
clearly infiltrated, and CEP was confirmed. Fetal
heart rate was present in two of the three embryos.
The patient was consulted about the diagnosis
and available treatment strategies. She did not
accept medical treatment with methotrexate. After
getting the informed consent and under general
anesthesia, cerclage sutures (without tightening)
were placed around the cervical canal. Then,
cervical arteries on 3 and 9 hours were clamped,
and curettage was done, and conception tissues
were removed completely. Then McDonald cer-
clage suture was tied tightly. During and after
the procedure, the patient received oxytocin intra-
venously. Consequently, in the next few hours,
vaginal bleeding decreased to minimal amount
and vital signs remained within normal limits, and
there was no hematocrit change. Next day, B-HCG
dropped to 15,025 mIU/mL, and cerclage suture
was removed five days later. On follow-up day
32, serum B-HCG became negative. On follow-up
day 120, physical exam and ultrasound scan were
normal. Fortunately, six months later, the patient
came to my office reporting a new and normal
singleton pregnancy.
3. Discussion
This article describes first, a patient with CEP
preliminary misdiagnosed as aborting intrauterine
pregnancy before presentation to our hospital
and second, we managed to perform safely and
completely the fertility preservation surgery on
her. This article is written after getting patient’s
informed consent. There is a divergence of
preferences among health care providers for CEP
management which ranges from non-surgical
methods to radical hysterectomy. However,
a timely diagnosis increases the likelihood of
implementing a more conservative method and
retaining patient’s fertility (5).
CEP is a rare form of EP with a very high risk of
life-threatening hemorrhage and subsequent loss
of fertility due to hysterectomy. Its risk factors
are not fully understood (7), and the best medical
or surgical treatment strategy should be individ-
ualized. Our patient reported two spontaneous
abortions without previous uterine or cervical
surgery and present pregnancy was achieved by
assisted reproductive technology (ART). In 1994,
Ginsburg et al. reported the first case of a triplet
heterotopic gestation with a twin cervical preg-
nancy following IVF. The study underscored the
surveillance of concurrent CEP in IVF conception
(8).
The history of ART and painless bleeding beside
closed cervical os, regular contours of three ges-
tational sacs, and regular cardiac beats in two
fetuses, no movement of the intracervical sac with
gentle pressure to the cervix were enough diag-
nostic clues to differentiate CEP from incomplete
abortion in our patient. Also, it was differentiated
from scar pregnancy due to its location on the
posterior wall of endocervical canal.
Controversial medical and surgical CEPmanage-
ment strategies, gestational age, hemodynamic
status of the patient, fertility preservation request,
available facilities, and physician expertise are
important factors that should be considered for
each patient. Different medical and surgical ther-
apies are reported in medical publications. Single
or multidose systemic methotrexate (MTX), intrasac
injection of MTX or potassium chloride or absolute
ethanol, or combinations of these therapies (9, 10),
uterine artery embolization (UAE) (11), dilation and
curettage with balloon insertion (12), hysteroscopy
(13), and hysterectomy in uncontrolled hemorrhage
or failed medical management are practiced in
different centers. Case reports of cervical cerclage
are successfully reported for the management
of CEP especially in heterotopic pregnancies (14-
20). When there are contraindications for medical
therapy, or UAE, hysteroscopy are not available;
cerclage techniques are good choices for some
selected patients.
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In this case report, we chronicled the step-
wise sequence of clinical events that rotated a
conventional incomplete abortion into the most
recherché type of EP. However, the principal objec-
tive of this case report was to raise awareness
on EP and to introduce our possibly avoidable
stumbling blocks. First, in teaching hospitals with
ob-gyn residents on the first line of treatment.
Pragmatically this can imperil patient care by both
insufficient clinical experience and false confi-
dence. We suggest establishing comprehensive
protocols and solid supervision. Also, an accurate
and perceptive history taking can greatly assist
identifying the risk factors associated with EP and
strengthen the chance of timely diagnosis. Second,
the patient’s uncooperative attitude provoked a
one-month deferment of proper diagnosis. This
foregrounds the importance of education and psy-
chiatric consult in patients with an enduring history
of infertility. Last, the patient was admitted during
the two-week Iranian Norouz spring holidays which
accentuates the necessity of further caution on
occasions susceptible to suboptimal accessibili-
ties.
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